BFA
ICCC icon

BlackRock Fund Advisors’s ImmuCell ICCC Stock Holding History

BlackRock Fund Advisors’s Portfolio ICCC Stock Details ICCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$4K Hold
736
– – ﹤0.01% 4085
2016
Q3 		$6K Buy
736
+57
+8% +$415 ﹤0.01% 4034
2016
Q2 		$5K Buy
679
+64
+10% +$432 ﹤0.01% 4089
2016
Q1 		$4K Buy
615
+154
+33% +$1.03K ﹤0.01% 4119
2015
Q4 		$3K Buy
+461
New +$3.25K ﹤0.01% 4230

Other funds holding ICCC

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SRC
Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
EFS
Essex Financial Services Essex, Connecticut $1.78B AUM 23.37% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock Fund Advisors's ICCC Position: Q4 2016 in Review

BlackRock Fund Advisors held its ImmuCell (ICCC) position steady in Q4 2016 at 736 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #4085.

BlackRock Fund Advisors first reported a position in ICCC in Q4 2015 and has held it in 5 quarters since. The position peaked at $6K in Q3 2016. 16 funds tracked by Wall St. Rank hold ICCC as of Q4 2016.

  • BlackRock Fund Advisors held 736 shares of ImmuCell worth $4K as of Q4 2016.
  • BlackRock Fund Advisors left its ImmuCell share count unchanged in Q4 2016.
  • ImmuCell made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #4085 holding.
  • BlackRock Fund Advisors first reported a position in ImmuCell in Q4 2015 and has held it in 5 quarters since.
  • BlackRock Fund Advisors's ImmuCell position peaked at $6K in Q3 2016.
  • 16 funds tracked by Wall St. Rank held ImmuCell as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.